PL372197A1 - Rozpuszczalne w wodzie pochodne fenyloglicyny - Google Patents

Rozpuszczalne w wodzie pochodne fenyloglicyny

Info

Publication number
PL372197A1
PL372197A1 PL03372197A PL37219703A PL372197A1 PL 372197 A1 PL372197 A1 PL 372197A1 PL 03372197 A PL03372197 A PL 03372197A PL 37219703 A PL37219703 A PL 37219703A PL 372197 A1 PL372197 A1 PL 372197A1
Authority
PL
Poland
Prior art keywords
water soluble
phenylglycine derivatives
phenylglycine
derivatives
soluble
Prior art date
Application number
PL03372197A
Other languages
English (en)
Inventor
Leo Alig
Katrin Groebke-Zbinden
Ulrike Obst
Original Assignee
F.Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F.Hoffmann-La Roche Ag filed Critical F.Hoffmann-La Roche Ag
Publication of PL372197A1 publication Critical patent/PL372197A1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/42Oxygen atoms attached in position 3 or 5

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Peptides Or Proteins (AREA)
  • Pyridine Compounds (AREA)
PL03372197A 2002-02-06 2003-01-30 Rozpuszczalne w wodzie pochodne fenyloglicyny PL372197A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02002009 2002-02-06

Publications (1)

Publication Number Publication Date
PL372197A1 true PL372197A1 (pl) 2005-07-11

Family

ID=27675597

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03372197A PL372197A1 (pl) 2002-02-06 2003-01-30 Rozpuszczalne w wodzie pochodne fenyloglicyny

Country Status (19)

Country Link
US (1) US6642386B2 (pl)
EP (1) EP1474391A1 (pl)
JP (1) JP2005522435A (pl)
KR (1) KR20040082411A (pl)
CN (1) CN1628099A (pl)
AR (1) AR038480A1 (pl)
AU (1) AU2003244474B2 (pl)
BR (1) BR0307469A (pl)
CA (1) CA2474027A1 (pl)
GT (1) GT200300030A (pl)
JO (1) JO2241B1 (pl)
MX (1) MXPA04007500A (pl)
PA (1) PA8564801A1 (pl)
PE (1) PE20030905A1 (pl)
PL (1) PL372197A1 (pl)
RU (1) RU2283305C2 (pl)
TW (1) TW200303744A (pl)
UY (1) UY27653A1 (pl)
WO (1) WO2003066588A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20010427A2 (en) * 1998-12-14 2002-06-30 Hoffmann La Roche Phenylglycine derivatives
EP1594845A4 (en) 2003-02-11 2008-05-21 Bristol Myers Squibb Co BENZENE ACETAMIDE COMPOUNDS USEFUL AS SERINE PROTEASE INHIBITORS
US7122559B2 (en) 2003-02-11 2006-10-17 Bristol-Myers Squibb Company Phenylglycine derivatives useful as serine protease inhibitors
EP1856096B1 (en) 2005-01-10 2010-09-01 Bristol-Myers Squibb Company Phenylglycinamide derivatives useful as anticoagulants
DE602006011752D1 (de) * 2005-06-24 2010-03-04 Bristol Myers Squibb Co Als antikoagulationsmittel geeignete phenylglycinamid- und pyridylglycinamidderivate

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20010427A2 (en) 1998-12-14 2002-06-30 Hoffmann La Roche Phenylglycine derivatives
US6548694B2 (en) 2000-05-23 2003-04-15 Hoffman-La Roche Inc. N-(4-carbamimidoyl-phenyl)-glycine derivatives

Also Published As

Publication number Publication date
KR20040082411A (ko) 2004-09-24
JO2241B1 (en) 2004-10-07
US20030166683A1 (en) 2003-09-04
JP2005522435A (ja) 2005-07-28
CN1628099A (zh) 2005-06-15
WO2003066588A1 (en) 2003-08-14
RU2004126940A (ru) 2005-08-10
CA2474027A1 (en) 2003-08-14
BR0307469A (pt) 2004-11-09
EP1474391A1 (en) 2004-11-10
PA8564801A1 (es) 2003-12-10
AU2003244474A1 (en) 2003-09-02
RU2283305C2 (ru) 2006-09-10
GT200300030A (es) 2003-09-12
UY27653A1 (es) 2003-08-29
AU2003244474B2 (en) 2006-05-11
AR038480A1 (es) 2005-01-19
TW200303744A (en) 2003-09-16
MXPA04007500A (es) 2004-11-10
US6642386B2 (en) 2003-11-04
PE20030905A1 (es) 2003-11-08

Similar Documents

Publication Publication Date Title
AP1850A (en) Spiroindolineplperidine derivatives
EG24050A (en) Heterocylocarboxamide derivatives
PL374718A1 (pl) Azolidynono-winylowe pochodne skondensowanego benzenu
IL166121A0 (en) Indole-3-sulphur derivatives
EP1522540A4 (en) AZAARENE DERIVATIVES
PL376475A1 (pl) Pochodne N-podstawionej 2-oksodihydropirydyny
ZA200500437B (en) 1-heterocyclyalkyl-3-sulfonazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands
SI1594840T1 (sl) Derivati piperidin-benzensulfonamida
IL152581A0 (en) Phenylglycine derivatives
GB0317665D0 (en) Qinazoline derivatives
PT1682493E (pt) Derivados de aminoacetonitrilo
PL1606277T3 (pl) Pochodne imidazol-4-iloetynylo-pirydyny
IL166426A0 (en) N-biarylmethyl aminocycloalkanecarboxamide derivatives
PL373697A1 (pl) Pochodne izochinoliny
IL175189A0 (en) N-thiazol-2-yl-benzamide derivatives
PL1706373T3 (pl) Pochodne amidoacetonitrylu
AU2003222659A8 (en) 23-o-substituted 5-o-mycaminosyltylonide derivatives
PL371216A1 (pl) Pochodne izochinoliny
PL372197A1 (pl) Rozpuszczalne w wodzie pochodne fenyloglicyny
EP1531854A4 (en) O-DERIVATED NOCATHIACIN DERIVATIVES
GB0319793D0 (en) Pyridinylmorpholine derivatives
GB0213488D0 (en) 2-Naphthamide derivatives
AU2003243397A8 (en) Homo-camptothecin derivatives
GB0126407D0 (en) Water soluble capsules
PL377320A1 (pl) Pochodne indolilowe

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)